BOULDER, Colo., Oct. 20, 2021 (GLOBE NEWSWIRE) -- In the largest proteogenomic study of its kind to date, an international research team led by scientists at the Berlin Institute of Health at Charité ...
BOULDER, Colo., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced the launch of its high-plex proteomics platform, which ...
As the proteomics platform with the broadest coverage on the market today, the SomaScan Platform opens the study of proteins for biological discovery, from the identification of new biomarkers to the ...
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (LAB) (the “Company”) announced today that its SomaScan™ Platform played a pivotal role in a study published in ...
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that the Precision Health Research, Singapore (PRECISE-SG100K) selected the ...
The focus at the American Society of Human Genetics (ASHG) meeting has, historically, been the genome. This year, however, there is a lot of buzz around the proteome. Indeed, SomaLogic, a company ...
BOULDER, Colo., Oct. 27, 2022 (GLOBE NEWSWIRE) -- In a recent paper published earlier this month in Nature Scientific Reports, researchers at the National Institutes of Health conducted what may be ...
Novo Nordisk initiated study validates the power of proteomics to provide unique insights into mechanisms of action and expanded drug indications as well as the potential for shorter and smaller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results